Literature DB >> 20872143

Remnant gastric cancer: can the risk be predicted when planning initial surgery?

Christof Hottenrott.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 20872143     DOI: 10.1007/s00268-010-0805-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  13 in total

1.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

2.  Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management?

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 3.  Systems medicine: a real approach for future personalized oncology?

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-03       Impact factor: 2.533

4.  Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment.

Authors:  Dimitrios H Roukos; Christos Katsios; Theodore Liakakos
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

5.  Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian Knot"?

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

6.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

7.  Relationship between the histological type of initial lesions and the risk for the development of remnant gastric cancers after gastrectomy for synchronous multiple gastric cancers.

Authors:  Takeo Fujita; Naoto Gotohda; Shinichiro Takahashi; Toshio Nakagohri; Masaru Konishi; Taira Kinoshita
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

Review 8.  Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2010-01       Impact factor: 5.225

Review 9.  Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Authors:  Dimosthenis Ziogas; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-03-26       Impact factor: 5.344

10.  Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance.

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2009-10-20       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.